| P2093 | author name string | Jayeeta Roychoudhury | |
| | Nahid Ali | |
| | Roma Sinha | |
| | Partha Palit | |
| P2860 | cites work | Leishmaniasis worldwide and global estimates of its incidence | Q21134611 |
| | Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection | Q27304818 |
| | Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice | Q28477398 |
| | Drug resistance in leishmaniasis | Q29616242 |
| | Leishmanicidal activity of stearylamine-bearing liposomes in vitro | Q32066670 |
| | The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes | Q33273936 |
| | Liposomes: from biophysics to the design of peptide vaccines. | Q33646646 |
| | Antileishmanial activities of stearylamine-bearing liposomes | Q33979887 |
| | Exposure of phosphatidylserine on Leishmania amazonensis isolates is associated with diffuse cutaneous leishmaniasis and parasite infectivity | Q34264802 |
| | The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis | Q34940857 |
| | In vitro lysis of the bloodstream forms of Trypanosoma brucei gambiense by stearylamine-bearing liposomes | Q35311986 |
| | Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis. | Q35666558 |
| | Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection | Q36482756 |
| | Liposomal amphotericin B for the treatment of visceral leishmaniasis | Q36581549 |
| | Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1. | Q36616938 |
| | Chemotherapy of leishmaniasis: past, present and future | Q36800448 |
| | Differences in expression and exposure of promastigote and amastigote membrane molecules in Leishmania tropica | Q37074940 |
| | Therapy of leishmaniasis: Superior efficacies of liposome-encapsulated drugs | Q37589185 |
| | Drug delivery strategies for therapy of visceral leishmaniasis | Q37702257 |
| | Cationic nanoparticles for delivery of amphotericin B: preparation, characterization and activity in vitro | Q38787429 |
| | Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice. | Q39955167 |
| | Antileishmanial activity of antimonials entrapped in liposomes | Q40131005 |
| | A molecular mechanism for lipopolysaccharide protection of Gram-negative bacteria from antimicrobial peptides. | Q40456986 |
| | Temporins, small antimicrobial peptides with leishmanicidal activity. | Q40472017 |
| | The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes | Q40847001 |
| | The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide | Q42125882 |
| | Modulation of murine liver macrophage clearance of liposomes by diethylstilbestrol. The effect of vesicle surface charge and a role for the complement receptor Mac-1 (CD11b/CD18) of newly recruited macrophages in liposome recognition | Q43842885 |
| | Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages | Q43998687 |
| | Visceral leishmaniasis: drug carrier system characteristics and the ability to clear parasites from the liver, spleen and bone marrow in Leishmania donovani infected BALB/c mice | Q44104322 |
| | Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India | Q44204672 |
| | Functionality of drug efflux pumps in antimonial resistant Leishmania donovani field isolates. | Q46047210 |
| | Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses | Q46497429 |
| | Mimicry of apoptotic cells by exposing phosphatidylserine participates in the establishment of amastigotes of Leishmania (L) amazonensis in mammalian hosts | Q46902206 |
| | Stearylamine-bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserine | Q46927876 |
| | The effects of charge and size on the interaction of unilamellar liposomes with macrophages | Q47240091 |
| | Liposome disposition in vivo. III. Dose and vesicle-size effects | Q47274977 |
| | The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production. | Q47373276 |
| | Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles | Q47401757 |
| | Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis. | Q51778296 |
| | Comparison of liposome based antigen delivery systems for protection against Leishmania donovani. | Q53366513 |
| | The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependent. | Q54384876 |
| | Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. | Q54563374 |
| | A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog | Q56798202 |
| | Comparison of the Depot Effect and Immunogenicity of Liposomes Based on Dimethyldioctadecylammonium (DDA), 3β-[N-(N′,N′-Dimethylaminoethane)carbomyl] Cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium Propane (DOTAP): Prolonged Liposome | Q57955477 |
| | Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response | Q57955486 |
| | Characterization of cationic liposomes. Influence of the bilayer composition on the kinetics of the liposome breakdown | Q59652285 |
| | Leishmania donovani: Surface membrane carbohydrates of promastigotes | Q67010904 |
| | Surface charge of macrophages and their interaction with charged particles | Q67922748 |
| | Protection of Toxoplasma gondii-infected mice by stearylamine-bearing liposomes | Q68811888 |
| | Interaction of antigens with dimethyldioctadecylammonium bromide, a chemically defined biological response modifier | Q70507991 |
| | Interactions of liposomes with the reticuloendothelial system. II: Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages | Q71861441 |
| | Antimony quantification in Leishmania by electrothermal atomic absorption spectroscopy | Q72810170 |
| | Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8(+) T-cell responses in vivo | Q73172828 |
| | Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis | Q77387081 |
| | Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins | Q78199050 |
| | Interaction of sitamaquine with membrane lipids of Leishmania donovani promastigotes | Q80197268 |
| | Role of aquaglyceroporin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of Leishmania donovani | Q81595506 |
| | Structure-activity relationship for quaternary ammonium compounds hybridized with poly(methyl methacrylate) | Q84139118 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sodium stibogluconate | Q2757844 |
| | Leishmania donovani | Q1950752 |
| P304 | page(s) | 344-355 | |
| P577 | publication date | 2014-11-03 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani | |
| P478 | volume | 59 | |